Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2016 by Butantan Institute
Sponsor:
Information provided by (Responsible Party):
Butantan Institute
ClinicalTrials.gov Identifier:
NCT02406729
First received: March 30, 2015
Last updated: December 19, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2022
  Estimated Primary Completion Date: May 2018 (Final data collection date for primary outcome measure)